The House Oversight and Accountability Committee chaired by Rep. James Comer (R-KY) has summoned FDA Commissioner Robert Califf for a Congressional hearing on April 11. Among other issues like drug shortages and tobacco, the hearing will probe the FDA’s role in hemp markets.
Comer was critical of the FDA’s decision in 2022 to defer to Congress rather than act on CBD regulation. Besides being vocal about hemp issues, it does not appear the chairman has been able to affect change at the agency. From a committee
…
11.21.2024
Domestic US biodiesel blending helps lift October RFS RIN production
US domestic biodiesel blending of 147.5 million gallons in October produced a monthly high of 221.2 million renewable identification number (RIN) credits for January-October. This was 11.5% above September...
11.21.2024
CWG trades lower as broader animal fats markets hold steady
The US animal fats and oils markets held steady on Thursday November 21, with limited trading as attention shifted toward broader macroeconomic factors and...
11.21.2024
October commercial cattle, hog production above 2023
US animal protein prices were steady on Thursday November 21. Limited trade was reported from market sources due to the proximity of the extended Thanksgiving holiday weekend in the...